SL
ARWR icon

Salomon & Ludwin’s Arrowhead Research ARWR Stock Holding History

Salomon & Ludwin’s Portfolio ARWR Stock Details ARWR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-1,046
Closed -$66.8K – 2103
2025
Q4 		$66.8K Buy
1,046
+109
+12% +$5.34K 0.01% 329
2025
Q3 		$33.8K Buy
+937
New +$20.6K ﹤0.01% 515

Other funds holding ARWR

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
FAM
Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return

Salomon & Ludwin's ARWR Position: Q1 2026 in Review

Salomon & Ludwin sold out of Arrowhead Research (ARWR) in Q1 2026, closing a stake of 1,046 shares — an estimated $66.8K sold.

Salomon & Ludwin first reported a position in ARWR in Q3 2025 and held it in 2 quarters. The position peaked at $66.8K in Q4 2025. 436 funds tracked by Wall St. Rank hold ARWR as of Q1 2026.

  • Salomon & Ludwin reported no remaining Arrowhead Research position as of Q1 2026 after selling out during the quarter.
  • Salomon & Ludwin sold 1,046 Arrowhead Research shares in Q1 2026, an estimated $66.8K.
  • Salomon & Ludwin first reported a position in Arrowhead Research in Q3 2025 and held it in 2 quarters.
  • Salomon & Ludwin's Arrowhead Research position peaked at $66.8K in Q4 2025.
  • 436 funds tracked by Wall St. Rank held Arrowhead Research as of Q1 2026.

Based on Salomon & Ludwin's 13F filing for Q1 2026, filed 11 May 2026.